Lassa virus (LASV), belonging to the family Arenaviridae, causes severe 21 haemorrhagic manifestations and is associated with a high mortality rate in 22 humans. Thus, it is classified as a biosafety level (BSL)-4 agent. Since counter 23 measures for LASV diseases are yet to be developed, it is important to elucidate 24 the molecular mechanisms underlying the life cycle of the virus, including its viral 25 and host cellular protein interactions. These underlying molecular mechanisms 26 may serve as the key for developing novel therapeutic options. Lymphocytic 27 choriomeningitis virus (LCMV), a close relative of LASV, is usually asymptomatic 28 and is categorised as a BSL-2 agent. In the present study, we visualised the 29 transport of viral matrix Z protein in LCMV-infected cells using live-cell imaging 30 microscopy. We demonstrated that the transport of Z protein is mediated by 31 polymerised microtubules. Interestingly, the transport of LASV Z protein showed 32 characteristics similar to those of Z protein in LCMV-infected cells. The live-cell 33 imaging system using LCMV provides an attractive surrogate measure for 34 studying arenavirus matrix protein transport in BSL-2 laboratories. In addition, it 35 could be also utilised to analyse the interactions between viral matrix proteins 36 4 and the cellular cytoskeleton, as well as to evaluate the antiviral compounds that 37 target the transport of viral matrix proteins. 38 39 40
Treatment of cells with cytoskeleton-modulating drugs
Cells were treated with 15 μM nocodazole (Sigma), 0.3 μM cytochalasin D 122 (Sigma), or 0.15% dimethyl sulfoxide (DMSO, Sigma) (24). These chemicals Image processing and analysis 126 The images and movie sequences obtained through the observation were 127 processed and analysed manually using the Fiji plug-in "MTrackJ" (25, 26) .
128
analysed the intracellular movement of Z protein in LASV Z protein-expressing 183 cells ( Fig. 4a ). Huh-7 cells were first transfected with 1 μg of pCAGGS-Z-GFP, 184 followed by cytoskeleton-modulating drugs, as described above. Although neither 185 DMSO nor cytochalasin D influenced Z protein movement, treatment with 186 nocodazole abolished Z protein movement in the short duration (Fig. 4b, c, d) .
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The transport of Z proteins was found to be mediated via polymerised 188 microtubules in the long duration (Fig, 4e, protein transport in LCMV-infected cells. Huh-7 cells were infected and 342 transfected as described in Fig. 1(b) , and treated either with DMSO (control), 
Figure legend
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The number indicates mean ± SD (nm/s). The effect of cytoskeleton-modulating drugs on LCMV Z protein transport for long duration. Huh-7 cells were infected and transfected as described in Fig. 1(b Fig. 4 (a) , and treated either with DMSO (a), or nocodazole (b) at 24 h p.i. to 
